EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection

Summary

The purpose of this study is to compare the safety and effectiveness of performing oral reconstructive surgeries using either AlloDerm, a product commonly used for this purpose, or AlloDerm that has been overlaid with the subject's oral mucosal cells and developed into a type of graft that is called an ex vivo produced oral mucosal equivalent, EVPOME.

Timeline

Start

2013-09

Primary completion

2014-11

Completion

2015-12

Outcome

Outcome not reported

Stopped: “Loss of cGMP facility to manufacture product used in clinical trial.”

Drugs

Indications

No indication recorded.